Functional dissociation between serotonergic pathways in dorsal and ventral hippocampus in psychotomimetic drug-induced locomotor hyperactivity and prepulse inhibition in rats

European Journal of Neuroscience

Volumn 20, Issue 12, 2004, Pages 3424-3432

  Kusljic, Snezana ^a,b   Van Den Buuse, Maarten ^a,b  

^a FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Amphetamine; Dopamine; Hippocampus; Phencyclidine; Schizophrenia; Serotonin

Indexed keywords

5,7 DIHYDROXYTRYPTAMINE; AMPHETAMINE; NEUROTOXIN; PENTOBARBITAL; PHENCYCLIDINE; SEROTONIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN FUNCTION; BRAIN REGION; CONTROLLED STUDY; DORSAL HIPPOCAMPUS; DORSAL RAPHE NUCLEUS; HIPPOCAMPUS; HYPERACTIVITY; LOCOMOTION; MALE; MEDIAN RAPHE NUCLEUS; NONHUMAN; PATHOPHYSIOLOGY; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; SEROTONINERGIC SYSTEM; STEREOTAXIC SURGERY; VENTRAL HIPPOCAMPUS;

AMPHETAMINE; ANIMALS; HALLUCINOGENS; HIPPOCAMPUS; HYPERKINESIS; MALE; NEURAL INHIBITION; NEURAL PATHWAYS; PHENCYCLIDINE; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; STARTLE REACTION;

EID: 10944228481     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2004.03804.x     Document Type: Article

References (62)

1. Abi-Dargham, A., Laruelle, M., Aghajanian, G.K., Charney, D. & Krystal, J. (1997) The role of serotonin in the pathophysiology and treatment of schizophrenia. J. Neuropsych. Clin. Neurosci., 9, 1-17.
2. Adell, A. & Myers, R.D. (1995) Selective destruction of midbrain raphe nuclei by 5,7-DHT: is brain 5-HT involved in alcohol drinking in Sprague-Dawley rats? Brain Res., 693, 70-79.
3. Amaral, D.G. & Witter, M.P. (1989) The three-dimensional organization of the hippocampal formation: a review of anatomical data. Neuroscience, 31, 571-591.
4. Azmitia, E.C. & Whitaker-Azmitia, P.M. (1995) Anatomy, cell biology, and plasticity of the serotonergic system. Neuropsychopharmacological implications for the actions of psychotropic drugs. In Bloom, F.E. & Kupfer, D.J. (Eds), Psychopharmacology: the Fourth Generation of Progress. Raven Press, New York, pp. 443-449.
5. Bast, T. & Feldon, J. (2003) Hippocampal modulation of sensorimotor processes. Prog. Neurobiol., 70, 319-345.
6. Baumgarten, H.G., Klemm, H.P., Sievers, J. & Schlossberger, H.G. (1982) Dihydroxytryptamines as tools to study the neurobiology of serotonin. Brain Res. Bull., 9, 131-150.
7. Burns, L.H., Robbins, T.W. & Everitt, B.J. (1993) Differential effects of excitotoxic lesions of the basolateral amygdala, ventral subiculum and medial prefrontal cortex on responding with conditioned reinforcement and locomotor activity potentiated by intra-accumbens infusions of D-amphetamine. Behav. Brain Res., 55, 167-183.
8. Caine, S.B., Humby, T., Robbins, T.W. & Everitt, B.J. (2001) Behavioral effects of psychomotor stimulants in rats with dorsal or ventral subiculum lesions: locomotion, cocaine self-administration, and prepulse inhibition of startle. Behav. Neurosci., 115, 880-894.
9. Carlsson, A. & Lindqvist, M. (1963) Effect of chlorpromazine or haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain. Acta. Pharmacol. Toxicol., 20, 140-144.
10. Carlsson, A., Waters, N., Holm-Waters, S., Tedroff, J., Nilsson, M. & Carlsson, M.L. (2001) Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence. Annu. Rev. Pharmacol. Toxicol., 41, 237-260.
11. Csernansky, J.G. & Bardgett, M.E. (1998) Limbic-cortical neuronal damage and the pathophysiology of schizophrenia. Schizophrenia Bull., 24, 231-248.
12. David, H.N. & Abraini, J.H. (2003) Blockade of the locomotor stimulant effects of amphetamine by group I, group II, and group III metabotropic glutamate receptor ligands in the rat nucleus accumbens: possible interactions with dopamine receptors. Neuropharmacology, 44, 717-727.
13. 2-like dopamine receptor agonists and D-amphetamine by NMDA and non-NMDA glutamate receptor agonists and antagonists in the core of the rat nucleus accumbens. Neuropharmacology, 46, 179-191.
14. A receptors in schizophrenia: studies on the human dorsolateral prefrontal cortex. J. Neurochem., 72, 1593-1599.
15. Dierks, T., Linden, D.E., Jandl, M., Formisano, E., Goebel, R., Lanfermann, H. & Singer, W. (1999) Activation of Heschl's gyrus during auditory hallucinations. Neuron, 22, 615-621.
16. Drevets, W.C., Gautier, C., Price, J.C., Kupfer, D.J., Kinahan, P.E., Grace, A.A., Price, J.L. & Mathis, C.A. (2001) Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria. Biol. Psychiatry, 49, 81-96.
17. Duncan, E.J., Madonick, S.H., Parwani, A., Angrist, B., Rajan, R., Chakravorty, S., Efferen, T.R., Szilagyi, S., Stephanides, M., Chappell, P.B., Gonzenbach, S., Ko, G.N. & Rotrosen, J.P. (2001) Clinical and sensorimotor gating effects of ketamine in normals. Neuropsychopharmacology, 25, 72-83.
18. Finamore, T.L., Seybold, K.S., Noble, M. & Port, R.L. (2001) Contributions of hippocampal cellular damage and NMDA receptor dysfunction to behavioral markers of schizophrenia. Int. J. Neurosci., 109, 61-70.
19. Fletcher, P.J., Selhi, Z.F., Azampanah, A. & Sills, T.L. (2001) Reduced brain serotonin activity disrupts prepulse inhibition of the acoustic startle reflex. Effects of 5,7-dihydroxytryptamine and p-chlorophenylalanine. Neuropsychopharmacology, 24, 399-409.
20. French, S.J. & Totterdell, S. (2002) Hippocampal and prefrontal cortical inputs monosynaptically converge with individual projection neurons of the nucleus accumbens. J. Comp. Neurol., 446, 151-165.
21. Freund, T.F. & Buzsaki, G. (1996) Interneurons of the hippocampus. Hippocampus, 6, 347-470.
22. Gately, P.F., Segal, D.S. & Geyer, M.A. (1986) The behavioral effects of depletions of brain serotonin induced by 5,7-dihydroxytryptamine vary with time after administration. Behav. Neural Biol., 45, 31-42.
23. Geyer, M.A. & Braff, D.L. (1987) Startle habituation and sensorimotor gating in schizophrenia and related animal models. Schizophrenia Bull., 13. 643-668.
24. Geyer, M.A. & Markou, A. (1995) Animal models of psychiatric disorders. In Bloom, F. & Kupfer, D. (Eds) Psychopharmacology: the Fourth Generation of Progress. Raven Press, New York, pp. 787-798.
25. Geyer, M.A. & Swerdlow, N.R. (1998) Measurement of startle response, prepulse inhibition, and habituation. Current Protocols Neurosci., Unit 8.7, 8.7.1-8.7.15.
26. Geyer, M.A., Swerdlow, N.R., Mansbach, R.S. & Braff, D.L. (1990) Startle response models of sensorimotor gating and habituation deficits in schizophrenia. Brain Res. Bull., 25, 485-498.
27. Harrison, P.J. (1999) The neuropathology of schizophrenia. Brain, 122, 593-624.
28. Heckers, S., Rauch, S.L., Goff, D., Savage, C.R., Schacter, D.L., Fischman, A.J. & Alpert, N.M. (1998) Impaired recruitment of the hippocampus during conscious recollection in schizophrenia. Nat. Neurosci., 1, 318-323.
29. Hitchcott, P.K. & Phillips, G.D. (1997) Amygdala and hippocampus control dissociable aspects of drug-associated conditioned rewards. Psychopharmacology (Berl.), 131, 187-195.
30. Jentsch, J.D., Taylor, J.R. & Roth, R.H. (1998) Subchronic phencyclidine administration increases mesolimbic dopaminergic system responsivity and augments stress- and psychostimulant-induced hyperlocomotion. Neuropsychopharmacology, 19, 105-113.
31. Jongen-Relo, A.L., Kaufmann, S. & Feldon, J. (2002) A differential involvement of the shell and core subterritories of the nucleus accumbens of rats in attentional processes. Neuroscience, 111, 95-109.
32. Jonsson, G. (1980) Chemical neurotoxins as denervation tools in neurobiology. Ann. Rev. Neurosci., 3, 169-187.
33. Kapur, S. & Remington, G. (1996) Serotonin-dopamine interaction and its relevance to schizophrenia. Am. J. Psychiatry, 153, 466-476.
34. Koch, M. & Schnitzler, H.U. (1997) The acoustic startle response in rats - circuits mediating evocation, inhibition and potentiation. Behav. Brain Res., 89, 35-49.
35. Kusljic, S., Copolov, D.L. & van den Buuse, M. (2003) Differential role of serotonergic projections arising from the dorsal and median raphe nuclei in locomotor hyperactivity and prepulse inhibition. Neuropsychopharmacology, 28, 2138-2147.
36. Laruelle, M., Abi-Dargham, A., Casanova, M.F., Toti, R., Weinberger, D.R. & Kleinman, J.E. (1993) Selective abnormalities of prefrontal serotonergic receptors in schizophrenia. A postmortem study. Arch. Gen. Psychiatry, 50, 810-818.
37. Laruelle, M., Abi-Dargham, A., van Dyck, C.H., Gil, R., D'Souza, C.D., Erdos, J., McCance, E., Rosenblatt, W., Fingado, C., Zoghbi, S.S., Baldwin, R.M., Seibyl, J.P., Krystal, J.H., Charney, D.S. & Innis, R.B. (1996) Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc. Natl Acad. Sci. USA, 93, 9235-9240.
38. Lehmann, O., Jeltsch, H., Bertrand, F., Lazarus, C., Will, B. & Cassel, J. (2000) When injected into the fimbria-fornix/cingular bundle, not in the raphe, 5,7-dihydroxytryptamine prevents amphetamine-induced hyperlocomotion. Behav. Brain Res., 114, 213-217.
39. Lipska, B.K., Jaskiw, G.E., Arya, A. & Weinberger, D.R. (1992) Serotonin depletion causes long-term reduction of exploration in the rat. Pharmacol. Biochem. Behav., 43, 1247-1252.
40. Lipska, B.K., Swerdlow, N.R., Geyer, M.A., Jaskiw, G.E., Braff, D.L. & Weinberger, D.R. (1995) Neonatal excitotoxic hippocampal damage in rats causes post-pubertal changes in prepulse inhibition of startle and its disruption by apomorphine. Psychopharmacology (Berl.), 122, 35-43.
41. Martin, P., Carlsson, M.L. & Hjorth, S. (1998a) Systemic PCP treatment elevates brain extracellular 5-HT: a microdialysis study in awake rats. Neuroreport, 9, 2985-2988.
42. 2A receptor antagonism is dependent on increased serotonergic tone. J. Neurol Transm., 105, 365-396.
43. McQuade, R. & Sharp, T. (1997) Functional mapping of dorsal and median raphe 5-hydroxytryptamine pathways in forebrain of the rat using microdialysis. J. Neurochem., 69, 791-796.
44. Meltzer, H.Y., Li, Z., Kaneda, Y. & Ichikawa, J. (2003) Serotonin receptors: their key role in drugs to treat schizophrenia. Progr. Neuro-Psychopharmacol. Biol. Psych., 27, 1159-1172.
45. Mokler, D.J., Lariviere, D., Johnson, D.W., Theriault, N.L., Bronzino, J.D., Dixon, M. & Morgane, P.J. (1998) Serotonin neuronal release from dorsal hippocampus following electrical stimulation of the dorsal and median raphe nuclei in conscious rats. Hippocampus, 8, 262-273.
46. Paxinos, G. & Watson, C. (1998) The Rat Brain in Stereotaxic Co-Ordinates, 4th edn. Academic Press, New York.
47. Pitkanen, A., Pikkarainen, M., Nurminen, N. & Ylinen, A. (2000) Reciprocal connections between the amygdala and the hippocampal formation, perirhinal cortex, and postrhinal cortex in rat. A review. Ann. NY Acad. Sci., 911, 369-391.
48. Pradhan, S.N. (1984) Phencyclidine (PCP): some human studies. Neurosci. Biobehav. Rev., 8, 493-501.
49. Sachdev, P. (1998) Schizophrenia-like psychosis and epilepsy: the status of the association. Am. J. Psychiatry, 155, 325-336.
50. Scarr, E., Copolov, D.L. & Dean, B. (2001) A proposed pathological model in the hippocampus of subjects with schizophrenia. Clin. Exp. Pharmacol. Physiol., 28, 70-73.
51. Silbersweig, D.A., Stern, E., Frith, C., Cahill, C., Holmes, A., Grootoonk, S., Seaward, J., McKenna, P., Chua, S.E., Schnorr, L. & et al. (1995) A functional neuroanatomy of hallucinations in schizophrenia. Nature, 378, 176-179.
52. Swerdlow, N.R., Braff, D.L., Taaid, N. & Geyer, M.A. (1994) Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients. Arch. Gen. Psychiatry, 51, 139-154.
53. Swerdlow, N.R. & Geyer, M.A. (1998) Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia. Schizophrenia Bull., 24, 285-301.
54. Swerdlow, N.R., Lipska, B.K., Weinberger, D.R., Braff, D.L., Jaskiw, G.E. & Geyer, M.A. (1995) Increased sensitivity to the sensorimotor gating-disruptive effects of apomorphine after lesions of medial prefrontal cortex or ventral hippocampus in adult rats. Psychopharmacology (Berl.), 122, 27-34.
55. Swerdlow, N.R., Taaid, N., Halim, N., Randolph, E., Kim, Y.K. & Auerbach, P. (2000) Hippocampal lesions enhance startle gating-disruptive effects of apomorphine in rats: a parametric assessment. Neuroscience, 96, 523-536.
56. Van den Buuse, M. & Eikelis, N. (2001) Estrogen increases prepulse inhibition of acoustic startle in rats. Eur. J. Pharmacol., 425, 33-41.
57. Velakoulis, D., Pantelis, C., McGorry, P.D., Dudgeon, P., Brewer, W., Cook, M., Desmond, P., Bridle, N., Tierney, P., Murrie, V., Singh, B. & Copolov, D. (1999) Hippocampal volume in first-episode psychoses and chronic schizophrenia: a high-resolution magnetic resonance imaging study. Arch. Gen. Psychiatry, 56, 133-141.
58. Verwer, R.W., Meijer, R.J., Van Uum, H.F. & Witter, M.P. (1997) Collateral projections from the rat hippocampal formation to the lateral and medial prefrontal cortex. Hippocampus, 7, 397-402.
59. Vorel, S.R., Liu, X., Hayes, R.J., Spector, J.A. & Gardner, E.L. (2001) Relapse to cocaine-seeking after hippocampal theta burst stimulation. Science, 292, 1175-1178.
60. Weinberger, D.R. (1999) Cell biology of the hippocampal formation in schizophrenia. Biol. Psychiatry, 45, 395-402.
61. Wiley, J.L. (1994) Clozapine's effects on phencyclidine-induced disruption of prepulse inhibition of the acoustic startle response. Pharmacol. Biochem. Behav., 49, 1025-1028.
62. Zhang, W.N., Bast, T. & Feldon, J. (2002) Prepulse inhibition in rats with temporary inhibition/inactivation of ventral or dorsal hippocampus. Pharmacol. Biochem. Behav., 73, 929-940.